Sobi™ Satellite Symposium

Agenda:

Welcome & Introduction - Jan Astermark, Sweden
Evolving Goals in Haemophilia A: From Concept to Reality - Maria Elisa Mancuso, Italy
Realising new Possibilities for Children with Haemophilia A - Christoph Königs, Germany
Transforming Clinical Perspectives in Adults with Haemophilia A - Robert Klamroth, Germany
Transitioning From Efanesoctocog alfa Clinical Trials to the Real-World Practice - Panel discussion
Closing Remarks - Jan Astermark, Sweden
 

Publication
  • EAHAD •
  • 7 February, 2025 •
  • •

Efanesoctocog Alfa for the Perioperative Management of Patients with Severe Haemophilia A: 4 years of Experience in the XTEND Clinical Program

Anthony K. C. Chan, Flora Peyvandi, Annette von Drygalski, Sandrine Meunier, Elena Santagostino, Linda Bystrická, Jennifer Dumont , Lara Mamikonian, Umer Khan, Liane Khoo, Robert Klamroth

Available materials

Oral Presentation
Publication
  • EAHAD •
  • 7 February, 2025 •
  • •

Two-Year Clinical Outcomes of Once-Weekly Efanesoctocog Alfa Prophylaxis in Children with Severe Hemophilia A: Second Interim Analysis of the XTEND-ed Phase 3 Study

Lynn Malec, Beatrice Nolan, Anthony K. C. Chan, Manuela Albisetti, Sheng-Chieh Chou, Bulent Zulfikar, Mindy Simpson, Liqi Feng, Helena Palmborg, Graham Neill, Lydia Abad-Franch, Sriya Gunawardena, Karin Fijnvandraat

Available materials

Oral Presentation
Publication
  • EAHAD •
  • 5 February, 2025 •
  • •

Real-World Effectiveness and Usage of a Recombinant Factor VIII Fc: Interim Analysis in Adults from the 48-Month Prospective, Observational A-MORE Study

Olga Benitez Hidalgo, Anna Olsson, Karina Meijer, Carmen Escuriola-Ettingshausen, Flora Peyvandi, Andreu Schoenenberger López, Markus Fusser, Stefan Lethagen

Available materials

Poster
Publication
  • EAHAD •
  • 5 February, 2025 •
  • •

Real-World Effectiveness and Usage of a Recombinant Factor VIII Fc: Interim Analysis in Children and Adolescents from the 48-Month Prospective, Observational A-MORE Study

Martin Olivieri, Pasi Huttunen, Chiara Biasoli, Christoph Königs, Barbara Faganel Kotnik, Andreu Schoenenberger López, Markus Fusser, Stefan Lethagen

Available materials

Poster
Publication
  • ISTH •
  • 24 June, 2025 •
  • •

Major Surgical Outcomes with Efanesoctocog Alfa: 4 Years’ Experience in the XTEND Clinical Program

Liane Khoo, Robert Klamroth, Annette von Drygalski, Sandrine Meunier, Davide Matino, Umer Khan, Elena Santagostino, Lara Mamikonian, Linda Bystrická, Graham Neill, Flora Peyvandi

Available materials

Oral Presentation
Publication
  • ISTH •
  • 24 June, 2025 •
  • •

Long-term observational joint health study in patients initiating efanesoctocog alfa: baseline data

Jonathan C. Roberts, Larissa Bornikova, Eric Grabowski, Amit Soni, Jennifer Dumont, Charlotte Sensinger, Nicole Tsao

Available materials

Poster
Publication
  • ISTH •
  • 24 June, 2025 •
  • •

Observational Study of Prophylactic Efanesoctocog Alfa for Joint Health in Hemophilia A: PROTECT-ALT

Te-Fu Weng, Yi-Chih Hsu, Chih-Wei Lee, Da-Ming Yeh, Tong-Ling Chien, Nicole Tsao, Ching-Min Chang

Available materials

Poster
Publication
  • ISTH •
  • 24 June, 2025 •
  • •

Joint health outcomes with efanesoctocog alfa in adults/adolescents from XTEND-1 continuing XTEND-ed

Christoph Königs, Annette von Drygalski, Cedric Hermans, Barbara A. Konkle, Paul Van der Valk, Liane Khoo, Nobuaki Suzuki, Erin Feng, Umer Khan, Linda Bystrická, Jennifer Dumont, Elena Santagostino, Lara Mamikonian, Robert Klamroth

Available materials

Poster
Sign up for alerts